September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Anxiety and depression in older patients with clinically significant cataract
Author Affiliations & Notes
  • Maria Jose Salgado-Canseco
    Ocular Epidemiology and Vision Health, Instituto de Oftalmología Conde de Valenciana, Mexico City, Mexico
  • Alvaro Garcia Perez
    Ocular Epidemiology and Vision Health, Instituto de Oftalmología Conde de Valenciana, Mexico City, Mexico
  • Enrique O Graue-Hernandez
    Cornea and Refractive Surgery, Instituto de Oftalmología Conde de Valenciana, Mexico City, Mexico
  • Jesus Arrieta
    Department of Anterior Segment, Instituto de Oftalmología Conde de Valenciana, Mexico City, Mexico
  • Aida Jimenez-Corona
    Ocular Epidemiology and Vision Health, Instituto de Oftalmología Conde de Valenciana, Mexico City, Mexico
    General Directorate of Epidemiology, Health Secretariat, Mexico City, Mexico
  • Footnotes
    Commercial Relationships   Maria Salgado-Canseco, None; Alvaro Garcia Perez, None; Enrique Graue-Hernandez, None; Jesus Arrieta, None; Aida Jimenez-Corona, None
  • Footnotes
    Support  none
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 6228. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Maria Jose Salgado-Canseco, Alvaro Garcia Perez, Enrique O Graue-Hernandez, Jesus Arrieta, Aida Jimenez-Corona; Anxiety and depression in older patients with clinically significant cataract. Invest. Ophthalmol. Vis. Sci. 2016;57(12):6228.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Several studies have shown a negative impact of cataract on the psychological health of older people, which predispose to lack of autonomy of these subjects.This study aimed to evaluate the anxiety and depression status in patients age ≥50 years with clinically significant cataract.

Methods : Cross-sectional study carried out from November 2014 to July 2015,including 391 patients ≥50 years of age with clinically significant cataract. The Hospital Anxiety and Depression Scale (HADS) that includes 14 items and 2 subscales (anxiety and depression) was used to assess these conditions.The score ranges from 0 to 21 for each subscale,and anxiety and depression symptoms (independently) were classified as follows:without (score, 0-7 and 0-8, respectively),borderline (score, 8-10 and 7-10, respectively),and presence of each condition (score for both, 11-21).Additionally,information about health self-perception and chronic conditions such as diabetes and hypertension was obtained.All analyses were performed using Stata 13.

Results : Of 391 patients (242 women and 149 men; average age 71.6 years, S.D. 10.2),227 had moderate/severe visual impairment and 164 were blind.Borderline anxiety was present in 8.5% of patients and anxiety in 5%,whereas borderline depression was present in 10.9% of patients and depression in 3.0%.Anxiety and depression were more frequent in patients age ≥70 years than in younger ones (27.7% and 20.4%, respectively) and in patients with blindness compared with those with moderate/severe visual impairment (30.5% and 20.3%, respectively).In multiple logistic regression analyses, separately, anxiety (OR=1.79, 95%IC 1.05-3.07, p=0.033) but not depression was associated with blindness (OR=1.53, 95%IC 0.88-2.66, p=0.129) after adjustment for age, sex, and health self-perception.Finally,the presence of anxiety or depression was significantly associated with age (OR=1.03, 95%IC 1.00-1.05, p=0.009), sex (OR=1.92, IC95% 1.13–3.26, p=0.016),poor health self-perception (OR=2.00, 95%IC95% 1.42–2.82, p=0.0001),and blindness (OR=1.68, 95%IC 1.03-2.74, p=0.036).

Conclusions : The main factors for both anxiety and depression in subjects with cataract were age, sex, health self-perception, and blindness.Visual impairment and blindness in patients with cataract is preventable; therefore, earlier psychotherapeutic interventions should be implemented to prevent or reverse symptoms of anxiety and depression in these patients.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×